Plavix Pharmacogenomic Marker Highlighted In JAMA
Article and editorial discuss potential for testing for non-responders to Plavix to guide treatment. Issue will be central to Effient launch - but will cardiologists embrace genetic screening?
Article and editorial discuss potential for testing for non-responders to Plavix to guide treatment. Issue will be central to Effient launch - but will cardiologists embrace genetic screening?